Projects and Grants per year
Personal profile
Education/Academic qualification
Master of Business Administration, University Of Kentucky
1999
Post Doctoral Fellow, Johns Hopkins University
1981
Residency, University Of Virginia
1979
Internship, West Virginia University
1976
Doctor of Medicine, West Virginia University
1975
Bachelor of Arts, Johns Hopkins University
1970
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Pharmacokinetic Study of Lecigon Enteral Suspension in Subjects With Advanced Parkinson's Disease: A Randomized, Cross-Over Study to Investigate the Pharmacokinetics of Entacapone, Carbidopa, and Levodopa (Lecigon) Versus Carbidopa and Levodopa Entera
Slevin, J. (PI)
12/20/24 → 12/19/26
Project: Research project
-
Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients with Motor Complications
Slevin, J. (PI)
Pharmaceutical Research Associates
11/21/24 → 11/20/26
Project: Research project
-
Autologous Peripheral Nerve Tissue Grafts Implanted into the Nucleus Basalis of Meynert and Substantia Nigra at the Time of Bilateral Deep Brain Stimulation in Parkinson Disease: A Report of 2 Cases
Daly, S. R., Quintero, J. E., Koehl, L., Wallace, E., Guduru, Z., Gurwell, J. A., Hines, T., Hixson, J., Hulou, S., Slevin, J. T., Schmitt, F. A., Gerhardt, G. A. & van Horne, C. G., 2025, In: Neurosurgery Practice. 7, 1Research output: Contribution to journal › Article › peer-review
Open Access -
Automated Imaging Differentiation for Parkinsonism
AIDP Study Group, May 12 2025, In: JAMA Neurology. 82, 5, p. 495-505 11 p.Research output: Contribution to journal › Article › peer-review
Open Access46 Scopus citations -
Two-year feasibility and safety of open-label autologous peripheral nerve tissue implantation during deep brain stimulation in patients with Parkinson's disease
Quintero, J. E., Chau, M. J., Slevin, J. T., Koehl, L., Gurwell, J. A., Wallace, E., Kryscio, R. J., El Khouli, R., Anderson-Mooney, A. J., Schmitt, F. A., Gerhardt, G. A. & van Horne, C. G., Mar 2025, In: Journal of Parkinson's Disease. 15, 2, p. 397-408 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
BouNDless Study Group, May 2024, In: The Lancet Neurology. 23, 5, p. 465-476 12 p.Research output: Contribution to journal › Article › peer-review
82 Scopus citations -
Recipient Reaction and Composition of Autologous Sural Nerve Tissue Grafts into the Human Brain
Colvett, I., Gilmore, A., Guzman, S., Ledreux, A., Quintero, J. E., Ginjupally, D. R., Gurwell, J. A., Slevin, J. T., Guduru, Z., Gerhardt, G. A., van Horne, C. G. & Granholm, A. C., Oct 2023, In: Journal of Clinical Medicine. 12, 19, 6121.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations